SCHEMBL697825

SCHEMBL697825

C=C(c1cccc(C(F)(F)F)c1C)c1nccn1Cc1ccccc1

nearest known ligand 0.49

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
RAB9A P51151 2/20 0.42
NPC1 O15118 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TP53 P04637 1/20 0.42
POLB P06746 1/20 0.40
RXFP1 Q9HBX9 1/20 0.40
P2RX7 Q99572 2/20 0.40
NR1H2 P55055 1/20 0.40
NR1H3 Q13133 1/20 0.40
DHODH Q02127 1/20 0.38
HDAC6 Q9UBN7 1/20 0.38
HSD17B10 Q99714 1/20 0.38
HSD11B1 P28845 1/20 0.37
TAS2R14 Q9NYV8 1/20 0.37
MEN1 O00255 1/20 0.36
KMT2A Q03164 1/20 0.36
OPRD1 P41143 1/20 0.36
TDP1 Q9NUW8 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL696698 0.88 RAB9A (0.47) RAB9ANPC1SMN1; SMN2TP53POLB
SCHEMBL699209 0.86 RAB9A (0.46) RAB9ANPC1SMN1; SMN2HSD17B10TDP1
SCHEMBL696960 0.84 RAB9A (0.44) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL697594 0.83 RAB9A (0.46) RAB9ANPC1SMN1; SMN2POLBHSD17B10
SCHEMBL696521 0.82 RAB9A (0.45) RAB9ANPC1SMN1; SMN2P2RX7HSD17B10
SCHEMBL696695 0.81 RAB9A (0.42) RAB9ANPC1SMN1; SMN2P2RX7HSD17B10
SCHEMBL698005 0.80 RAB9A (0.41) RAB9ANPC1SMN1; SMN2HSD17B10OPRD1
SCHEMBL697950 0.80 MEN1 (0.44) RAB9ANPC1SMN1; SMN2TP53P2RX7
SCHEMBL698833 0.80 RAB9A (0.42) RAB9ANPC1SMN1; SMN2HSD17B10MEN1
SCHEMBL705643 0.79 RAB9A (0.44) RAB9ANPC1SMN1; SMN2HSD17B10TDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2423199-A1 Substituted imidazoles and their use as pesticides Pfizer Limited (GB) 2012-02-29 EP disclosed
US-7825149-B2 Substituted imidazoles PFIZER LIMITED (GB) 2010-11-02 US disclosed
US-20090312326-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2009-12-17 US disclosed
US-7592362-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-09-22 US disclosed
US-7547718-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-16 US disclosed
US-7544706-B2 Substituted imidazoles PFIZER LIMITED (GB) 2009-06-09 US disclosed
US-20080125473-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-29 US disclosed
US-20080119536-A1 SUBSTITUTED IMIDAZOLES PFIZER LIMITED (GB) 2008-05-22 US disclosed
US-20070167506-A1 SUBSTITUTED IMIDAZOLES PFIZER INC. (US) 2007-07-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080125473-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885
US-20090312326-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885
US-20070167506-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885
US-20080119536-A1 SUBSTITUTED IMIDAZOLES ABL1, TYR, CYP3A4 RAB9A 777/4885NPC1 745/4885SMN1; SMN2 1394/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.